Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Predict S.P.A. Class B ( (IT:PRE) ) has issued an update.
Predict S.p.A. reported a significant revenue growth of approximately 90% in the first half of 2025, reaching €2.40 million, driven by its traditional SBUs, Imaging and People Support. Despite the growth, the company faced challenges with its innovative SBUs, Mistral and Digital Healthcare, due to public procurement complexities. The EBITDA was negative at €-0.27 million, reflecting ongoing investments in workforce and R&D. The company’s financial position remains cash positive, with no financial debt, although net results showed a slight decline compared to the previous year.
The most recent analyst rating on (IT:PRE) stock is a Buy with a EUR1.45 price target. To see the full list of analyst forecasts on Predict S.P.A. Class B stock, see the IT:PRE Stock Forecast page.
More about Predict S.P.A. Class B
Predict S.p.A. is an innovative SME operating in the healthcare sector, focusing on in vivo diagnostics. The company distributes ultrasound and radiological equipment and develops technologies in breath analysis and digital healthcare.
Average Trading Volume: 33,300
Technical Sentiment Signal: Strong Buy
Learn more about PRE stock on TipRanks’ Stock Analysis page.